Faster diagnosis and use of individualised treatments for congenital hyperinsulinism has led to major improvements in neurological and endocrine outcomes over time, say Finnish researchers.
Researchers have identified probable type 1 diabetes in children of an age more commonly associated with diagnosis of monogenic diabetes, raising the possibility that polygenic disease processes can begin in utero.
UK researchers have identified an increase in the number of childhood cases of new-onset type 1 diabetes during the COVID-19 pandemic, raising the possibility of a link with SARS-CoV-2 infection.
A major analysis covering three continents suggests that diabetic ketoacidosis remains unacceptably common among children newly identified with type 1 diabetes and shows few signs of improving.
Factors including age at diagnosis and the specific disease influence the likelihood of children with chronic endocrine conditions being lost to follow-up, show French study findings.
Prepubertal children with type 1 diabetes have greater variability in their blood glucose levels than older children, research suggests.
Rare forms of maturity onset diabetes of the young are frequently misdiagnosed as type 1 or even type 2 diabetes, say researchers, despite patients presenting with distinct characteristics.
Accuracy concerns offset flash glucose monitoring convenience in children with congenital hyperinsulinism
A trial of flash glucose monitoring shows that the technology is easy and convenient to use but may not be sufficiently accurate to be relied upon in children with congenital hyperinsulinism.
The risk of having a repeat episode of severe hypoglycaemia is elevated for at least 4 years after a previous episode in children with type 1 diabetes, although the risk is highest during the first year, researchers report.
Neonatal diabetes could be detected as early as day 5 of life using glucose measurements from dried blood spots, researchers report.